CAC Software vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Powerful Medical

AI Verdict

These tools are adjacent in their focus on cardiology AI but differ significantly in their diagnostic approach. Imbio's CAC Software analyzes CT scans for coronary artery calcification, providing a structural assessment of heart disease risk. PMcardio, on the other hand, interprets ECGs to detect a wide range of cardiac conditions, offering functional insights into immediate cardiac health at the point of care.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary need is to quantify coronary artery calcification from non-contrast chest CT scans to assess a patient's risk for coronary artery disease. This tool is ideal for radiologists and cardiologists who require automated image post-processing, Agatston scores, arterial age, and 3D visualizations to support cardiovascular risk assessment and population health screening.

View CAC Software →

Choose PMcardio if…

Choose PMcardio if your focus is on rapid, AI-powered interpretation of ECGs for the immediate assessment of over 50 cardiac conditions, particularly in acute care settings like emergency medicine or for general practitioners needing expert-level ECG analysis at the point of care. It's well-suited for detecting time-critical events such as STEMI/OMI and reduced LVEF, offering visual AI explainability and integration with mobile and EHR platforms.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud, On-premise, Partner platforms Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, making it highly accessible for clinicians at the point of care. Its freemium model also allows users to try the application with 5 free ECG analyses per month, lowering the barrier to entry. Imbio's CAC Software integrates into existing DICOM viewing workflows and offers automated processing, which is efficient for radiologists, but PMcardio's direct mobile accessibility and freemium model likely provide a broader and more immediate usability advantage for a wider range of healthcare professionals.

Clinical Value

PMcardio

PMcardio is clinically validated in over 25 studies and trusted by over 100,000 clinicians, demonstrating superior accuracy in detecting over 50 cardiac conditions, including STEMI/OMI and reduced LVEF. Imbio's CAC Software provides automated quantification of coronary artery calcification and outputs an Agatston score, arterial age, and calcified lesion mass and volume, which are valuable for risk assessment. However, PMcardio's broader diagnostic scope, extensive validation, and direct impact on acute care decisions give it a stronger clinical value proposition.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for 5 ECG analyses per month and a clear pricing structure for individual and team subscriptions. Imbio's CAC Software requires contacting them for pricing, which lacks transparency and may involve a more significant upfront investment. PMcardio's accessibility through its free tier and clear subscription options provides better value and flexibility for individual clinicians and smaller practices.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Imbio's CAC Software offers flexible deployment options including cloud, on-premise, and integration with partner platforms, and is designed to integrate into existing DICOM viewing workflows. PMcardio also offers enterprise integrations with EHR/CVIS and EMS systems, alongside its mobile and web platforms, and is GDPR and HIPAA compliant. While PMcardio highlights its organizational plans, Imbio's focus on seamless integration into established radiology workflows and multiple deployment options suggests comparable enterprise capabilities.

Innovation

PMcardio

PMcardio showcases significant innovation with its 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps, offering transparency into its AI's decision-making. Imbio's CAC Software utilizes deep-learning for automated image post-processing and 3D visualizations. However, PMcardio's explainable AI and its focus on real-time, actionable insights for a wider range of cardiac conditions represent a more innovative approach to clinical decision support.

Support & Docs

PMcardio

PMcardio provides a comprehensive 'Help Center' and 'FAQ' section, along with a 'Research' page detailing its publications and clinical studies, indicating robust documentation and support resources. Imbio's documentation and support details are not explicitly detailed in the provided information, though their integration with partner platforms suggests reliance on those partners for some support. PMcardio's transparent and readily available support resources give it an edge.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software PMcardio
Name CAC Software PMcardio
Company Imbio Powerful Medical
Description Automated image post-processing algorithms to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Key Features Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries, Outputs Agatston score, arterial age, calcified lesion mass and volume, Provides 3D visualizations and annotated images, Non-invasive analysis from non-contrast chest CT scans, Integrates into existing DICOM viewing workflow, Supports risk assessment for coronary artery disease, Deep-learning based analysis Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization

Videos

Demos, reviews, and walkthroughs featuring CAC Software and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software integrates into existing DICOM viewing workflows, providing annotated images and summary reports that can be read at a PACS workstation. PMcardio offers broader integration capabilities, connecting with existing ECG systems, EHR/CVIS, EMS systems, and communication tools, and can be launched from the EHR with results sent back to clinical systems.
Imbio's CAC Software demonstrates 'near perfect' agreement (Cohen's kappa of 0.936) with ground truth for 5-scale CVD risk categorization and high intraclass correlation coefficients (0.947-0.954) for quantitative metrics like Agatston score. PMcardio has shown high sensitivity and specificity for major ECG abnormalities (86% and 92% respectively) and atrial fibrillation (97% and 99% respectively) in primary care settings. Its Queen of Heartsu2122 AI model for STEMI detection has demonstrated twice the sensitivity of traditional criteria and an 81-90% reduction in false cath lab activations.
Imbio's CAC Software is designed for radiologists and cardiologists to assess coronary artery calcification from non-contrast chest CTs, aiding in coronary artery disease risk assessment. PMcardio is suitable for cardiologists, emergency medicine, and internal medicine, providing AI-powered ECG interpretations for over 50 cardiac conditions, including STEMI/OMI, reduced LVEF, and various arrhythmias, supporting rapid decision-making at the point of care.
Imbio's CAC Software is described as fully automated, integrating into the radiological workflow without adding steps, suggesting a minimal learning curve for physicians as it provides an aid to their analysis rather than requiring new operational procedures. PMcardio allows clinicians to start using the mobile or web app immediately without IT integration, indicating a relatively low learning curve for basic use, with more advanced organizational features available for health systems.
PMcardio for Organizations includes full audit trails for every pathway action, providing visibility into pathway execution across sites and teams to support QA, audits, and protocol optimization. The provided information for Imbio's CAC Software does not explicitly detail audit-trail features.
PMcardio for Organizations is built for health systems to scale across campuses and care settings without custom builds, offering a unified cardiac AI platform for acute care, screening, remote monitoring, and procedural analytics. It aims to standardize clinical decisions across every site and pathway. Imbio's CAC Software integrates into standard DICOM viewing workflows, which could facilitate multi-site deployment within existing imaging infrastructure, but specific multi-site rollout considerations or standardization features are not detailed.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.